Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$8.43B
sum of reported positions
Reported positions
590
Changes vs prior quarter
597
102 new · 88 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 459 measured positions in 8 quarters, the typical new or larger position finished −1.5 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 693K | $139M | 1.6% | |
| 1.03M | $126M | 1.5% | |
| 423K | $122M | 1.5% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $6.98B | $8.43B |
| Positions | 576 | 590 |
| Biggest line | — | NVIDIA 2% |
| 828K |
| $120M |
| 1.4% |
| 206K | $119M | 1.4% |
| 268K | $100M | 1.2% |
| 398K | $95M | 1.1% |
| 314K | $93.4M | 1.1% |
| 204K | $92.9M | 1.1% |
| 216K | $82.2M | 1.0% |
| 1.05M | $78.7M | 0.9% |
| 182K | $77.2M | 0.9% |
| 1.45M | $69.3M | 0.8% |
| 192K | $68M | 0.8% |
| 531K | $63.6M | 0.8% |
| 99K | $63.6M | 0.8% |
| 701K | $63.3M | 0.8% |
| 161K | $60.7M | 0.7% |
| 394K | $60.3M | 0.7% |
| 1.16M | $59.9M | 0.7% |
| 499K | $58.5M | 0.7% |
| 584K | $58.3M | 0.7% |
| 360K | $57.7M | 0.7% |
| 796K | $57.6M | 0.7% |
| 3.09M | $57.5M | 0.7% |
Primis Financial (FRST)
98K → 131K shares (+34%)
Farmers & Merchants Bancorp (FMAO)
51K → 68K shares (+33%)
Scholastic Corporation (SCHL)
35K → 44K shares (+26%)
Norwood Financial (NWFL)
56K → 60K shares (+7%)
Armour Residential REIT (ARR)
58K → 108K shares (+88%)
Kohl's Corp. (KSS)
71K → 106K shares (+49%)
Korn/Ferry International (KFY)
22K → 28K shares (+30%)
Tactile Systems Technology (TCMD)
49K → 61K shares (+23%)
Rigel Pharmaceuticals (RIGL)
37K → 46K shares (+23%)
Zymeworks (ZYME)
46K → 67K shares (+46%)
Ironwood Pharmaceuticals (IRWD)
278K → 408K shares (+47%)
Chimera Investment (CIM)
71K → 128K shares (+82%)
Atn International (ATNI)
29K → 62K shares (+113%)
Adient (ADNT)
69K → 83K shares (+19%)
B&G Foods (BGS)
95K → 380K shares (+299%)
Op Bancorp (OPBK)
36K → 96K shares (+165%)
Alpine Income Property Trust (PINE)
47K → 65K shares (+38%)
Dorian LPG Ltd. (LPG)
36K → 38K shares (+4%)
Supernus Pharmaceuticals, Inc. (SUPN)
23K → 26K shares (+12%)
Collegium Pharmaceutical, Inc. (COLL)
22K → 30K shares (+35%)
Innoviva, Inc. (INVA)
40K → 46K shares (+14%)
Pacira BioSciences, Inc. (PCRX)
30K → 35K shares (+18%)
Grupo Televisa, S.A.B. (TV)
142K → 189K shares (+33%)
INVESCO VARIABLE RATE PREFERRED
19K → 19K shares (+3%)
GLOBAL X FDS US PFD ETF
23K → 24K shares (+4%)